MedPath

The Effects of a Chinese Herbal Medicine (VGHBPH0) on Patients with Benign Prostatic Hyperplasia: A Pilot Study

Phase 1
Completed
Conditions
Benign Prostatic Hyperplasia
Registration Number
ITMCTR2000002937
Lead Sponsor
Center for Traditional Medicine, Taipei Veterans General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

1. Aged > 40 years old;
2. first-line BPH treatments >=3 months;
3. Moderate to severe BPH (IPSS >=8);
4. Stable life signs;
5. Volunteer to join this research.

Exclusion Criteria

1. Gonorrhea or urinary tract infection;
2. Urinary calculi, prostate cancer, bladder tumor and acute/chronic renal failure;
3. Bladder neck fibrosis, interstitial cystitis or urethral stricture;
4. Injured local organs, muscle and nerve caused by pelvic operation or trauma;
5. Upper urinary obstruction and hydrocele combined with damaged renal function;
6. Unable to commit to treatment because of commuting problems to the hospital.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
International Prostate Symptom Score;
Secondary Outcome Measures
NameTimeMethod
post-voiding residual urine;Urine flow;Aging Male Symptoms;
© Copyright 2025. All Rights Reserved by MedPath